Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: BMS tops Street, halts Opdivo head/neck trial early

    Bristol-Myers Squibb Co. (NYSE:BMY) reported 4Q15 and 2015 financial results that beat estimates and said a Phase III trial of Opdivo nivolumab to treat squamous cell carcinoma of the head and neck (SCCHN) was stopped …

    Published on 1/28/2016
  • FINANCIAL NEWS: Celgene to adjust 2017 guidance

    Celgene Corp. (NASDAQ:CELG) slid $5.10 to $97.21 on Thursday after reporting 4Q15 earnings and signaling that it will likely revise 2017 guidance.In response to a question on a conference call Thursday, Celgene EVP and …

    Published on 1/28/2016
  • FINANCIAL NEWS: Chinese antibody play Adagene raises $28M

    Adagene Inc. (Suzhou, China) raised $28 million in a series B round led by new investor GP Healthcare Capital. Also participating were new investor New World TMT and existing investors Eight Roads Ventures China (…

    Published on 1/28/2016
  • FINANCIAL NEWS: Adicet raises $51 million series A

    Adicet Bio Inc. (Menlo Park, Calif.) raised $51 million in a series A round led by OrbiMed. Other investors included Novartis Venture Fund and Pontifax. Adicet said it is developing preclinical universal immune cell …

    Published on 1/27/2016
  • FINANCIAL NEWS: Novartis contrasts Entresto, Cosentyx uptake

    Novartis AG (NYSE:NVS; SIX:NOVN) reported 4Q15 and full-year financial results and provided an update on the recent launches of two drugs it expects could become the pharma's biggest assets, heart failure drug Entresto …

    Published on 1/27/2016
  • FINANCIAL NEWS: Tarveda raises $38M series C

    Tarveda Therapeutics Inc. (Watertown, Mass.) raised $38 million in a series C round led by new investor Novo A/S (Hellerup, Denmark) and founding investor New Enterprise Associates. Existing investors Flagship Ventures,…

    Published on 1/27/2016
  • FINANCIAL NEWS: Exosome play Codiak closes $61M B round

    Exosome-based diagnostics and therapeutics play Codiak BioSciences Inc. (Cambridge, Mass.) said it closed a series B round with $61 million. Flagship Ventures and Arch Venture Partners co-led both the new round and …

    Published on 1/26/2016
  • FINANCIAL NEWS: Inivata closes L31.5M round

    Cancer diagnostics play Inivata Ltd. (Cambridge, U.K.) raised L31.5 million ($44.9 million) in a series A round. The company plans to accelerate clinical trials of its enhanced TAm-Seq circulating tumor DNA (ctDNA) …

    Published on 1/26/2016
  • FINANCIAL NEWS: Chinese CAR-T play CARsgen raises $30M

    CARsgen Therapeutics Co. Ltd. (Shanghai, China) raised $30 million in a series B round led by KTB Ventures and Jolly Innovation Ventures. Kaitai Capital and JIC GenesisFountain Healthcare Ventures also participated.…

    Published on 1/25/2016
  • FINANCIAL NEWS: Editas seeking valuation above $600M

    Gene editing company Editas Medicine Inc. (Cambridge, Mass.) amended its proposed IPO on NASDAQ and plans to sell 5.9 million shares at $16-$18. At $17, it would raise $100.3 million and be valued at $606.9 million. …

    Published on 1/25/2016
  • FINANCIAL NEWS: Pharmas, U.K. schools launch L40M Apollo fund

    Three pharmas and the tech transfer offices of three U.K. universities launched the L40 million ($57 million) Apollo Therapeutics Fund to support development of early stage projects arising from the universities. Apollo…

    Published on 1/25/2016
  • FINANCIAL NEWS: Akili raises $30.5M for therapeutic games

    Akili Interactive Labs Inc. (Boston, Mass.) raised $30.5 million in a venture round from investors including Jazz Venture Partners, Canepa Advanced Healthcare Fund and PureTech Health plc (LSE:PRTC). Akili is developing…

    Published on 1/22/2016
  • FINANCIAL NEWS: iCarbonX raising RMB700M

    Artificial intelligence newco iCarbonX has raised RMB100 million ($15.2 million) from Zhongyuan Union Stem Cell Bioengineering Corp. (Shanghai:600645) as part of a planned RMB700 million ($106.4 million) round, …

    Published on 1/22/2016
  • FINANCIAL NEWS: Abingworth closes $105M risk-sharing fund

    Abingworth closed a $105 million fund dedicated to risk-sharing investments in late-stage clinical therapeutic programs from biotech and pharma companies. The firm will invest its eleventh fund, Abingworth Clinical Co-…

    Published on 1/21/2016
  • FINANCIAL NEWS: bioMerieux spinout bioTheranostics raises $32M

    bioTheranostics Inc. raised $32 million in an equity round and said it will spin out from parent company bioMerieux S.A. (Euronext:BIM). MVM Life Science Partners led the round, in which Canepa Advanced Healthcare Fund …

    Published on 1/21/2016
  • FINANCIAL NEWS: Financial tracks

    Atlas Venture hired Tariq Kassum as an entrepreneur-in-residence. Kassum was VP and head of oncology business development at Takeda Pharmaceutical Co. Ltd. (Tokyo:4502).

    Published on 1/21/2016
  • FINANCIAL NEWS: vasopharm raises EUR 20M

    vasopharm GmbH raised EUR 20 million ($21.8 million) in a venture round co-led by existing investors Entrepreneurs Fund, Heidelberg Capital Private Equity and new investor Fort Rock Capital. Existing investors Bayern …

    Published on 1/21/2016
  • FINANCIAL NEWS: BeiGene sets IPO terms

    Cancer company BeiGene Ltd. (Beijing, China) set terms for its IPO on NASDAQ and now hopes to sell 5.5 million ADSs at $22-$24. At $23, it would raise $126.5 million and be valued at $685.9 million. Goldman Sachs, …

    Published on 1/20/2016
  • FINANCIAL NEWS: Chinese firms back Cocoon's L500M fund

    Cocoon Networks launched a L500 million ($715 million) London-based VC fund to invest in European startups. The fund, backed by Chinese investment companies China Equity Group and Hanxin Capital, will invest in start-…

    Published on 1/20/2016
  • FINANCIAL NEWS: AveXis files for $115M IPO

    Gene therapy company AveXis Inc. (Chicago, Ill.) filed to raise up to $115 million in an IPO on NASDAQ underwritten by Goldman Sachs, Jefferies, BMO Capital Markets and Chardan. In 1H17, AveXis hopes to begin pivotal …

    Published on 1/19/2016
  • FINANCIAL NEWS: Twist raises $61M in series D

    Twist Bioscience Corp. (San Francisco, Calif.) raised $61 million in a series D round. New investors WuXi Healthcare Ventures, Arch Overage Fund, Merieux Developpement, Cormorant Asset Management and Boris Nikolic …

    Published on 1/19/2016
  • FINANCIAL NEWS: UCL launches L50M fund

    University College London launched the UCL Technology Fund with L50 million ($71.5 million), which it plans to invest over five years in academic research it believes has commercial potential, including licensing …

    Published on 1/19/2016
  • FINANCIAL NEWS: 20/20 GeneSystems raises $4.5M in series A

    Diagnostic play 20/20 GeneSystems Inc. (Rockville, Md.) raised $4.5 million in a series A round. Investors included Ping An Ventures, which is the venture capital division of China's largest insurance company, and …

    Published on 1/15/2016
  • FINANCIAL NEWS: Biotechs end week with more losses

    Biotech stocks sank Friday along with the broader markets, ending a dismal week with heavy losses. The BioCentury 100 index slipped 129.90 (2%) to 5,185.32, as decliners outpaced gainers 83-16. The index fell 356.51 (6…

    Published on 1/15/2016
  • FINANCIAL NEWS: Oncobiologics files for IPO

    Oncobiologics Inc. (Cranbury, N.J.) filed to raise up to $115 million in an IPO on NASDAQ underwritten by Jefferies, Barclays and Cantor Fitzgerald. This year, the company intends to begin Phase III trials of two …

    Published on 1/15/2016

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993